Pharmacogenomic‐based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare system

Pharmacogenomics (PGx)‐based personalized medicine (PM) is increasingly utilized to guide treatment decisions for many drug‐disease combinations. Notably, London Health Sciences Centre (LHSC) has pioneered a PGx program that has become a staple for London‐based specialists. Although implementational...

Descripción completa

Detalles Bibliográficos
Autores principales: Subasri, Mathushan, Barrett, David, Sibalija, Jovana, Bitacola, Lisa, Kim, Richard B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604218/
https://www.ncbi.nlm.nih.gov/pubmed/34080317
http://dx.doi.org/10.1111/cts.13083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604218/
https://www.ncbi.nlm.nih.gov/pubmed/34080317
http://dx.doi.org/10.1111/cts.13083

Ejemplares similares